Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 23, 2022
Is the world ready for gene therapy?Louis P Garrison, Diane KleinermansPharmacology Research & Perspectives|May 8, 2022
An open-label randomized study of the relative absorption of gastro-resistant risedronate taken fasted or with food versus immediate-release risedronateDiane Kleinermans, Andrew Joyson, Heather WrayPharmacoeconomics|September 14, 2010
Regulatory benefit-risk assessment and comparative effectiveness research: strangers, bedfellows or strange bedfellows?Louis P GarrisonValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An OverviewLouis P GarrisonHealth Care Financing Review|November 6, 2014
Assessment of the effectiveness of supply-side cost-containment measuresLouis P GarrisonBritish Journal of Clinical Pharmacology|November 18, 2003
Voriconazole potentiates warfarin-induced prothrombin time prolongationLynn Purkins, Nolan Wood, Diane Kleinermans, et al.British Journal of Clinical Pharmacology|November 18, 2003
Voriconazole does not affect the steady-state pharmacokinetics of digoxinLynn Purkins, Nolan Wood, Diane Kleinermans, et al.British Journal of Clinical Pharmacology|November 18, 2003
Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazoleLynn Purkins, Nolan Wood, Diane Kleinermans, et al.Current Medical Research and Opinion|March 22, 2012
Retrospective outcomes studies for orphan diseases: challenges and opportunitiesPeter Sun, Louis P GarrisonPharmacoeconomics|February 4, 2024
Incorporating Real Option Value in Valuing Innovation: A Way ForwardMeng Li, Louis P GarrisonPageof 19